Live Breaking News & Updates on Vrinda Saraff

Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company based in Japan, will share new research that advances understanding about the real-world experiences and clinical characteristics of children, adolescents, and adults living with X-linked hypophosphatemia (XLH), a rare genetic metabolic bone disease. The findings will be presented in a series of poster presentations at the American Society for Bone and Mineral Research (AS ....

United Kingdom , United States , Zhiyi Li , Taliya Khan , Suma Uday , Asia Pacific , Kathryn Dahir , Vrinda Saraff , A Global Specialty Pharmaceutical Company , Outcomes Research At Kyowa Kirin North America , Mcmaster University , Kyowa Kirin Inc , Disease Monitoring Program Poster , Vanderbilt University Medical Center , Health Economics , Outcomes Research , Kyowa Kirin North , Vanderbilt University Medical , Birmingham Women , Kyowa Kirin , Adverse Event , Prescribing Information , North America , Kyowa Kirin North America , X Linked Hypophosphatemia , Poster Session ,